D-0446-2017 Class III Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0446-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Dec 20, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications; 18 month stability time point The recall status is terminated (terminated Jul 11, 2018). Affected quantity: 11,618 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 1, 2017
Initiation Date
Dec 20, 2016
Termination Date
Jul 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,618 bottles

Product description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Reason for recall

Failed Dissolution Specifications; 18 month stability time point

Distribution pattern

Nationwide

Code information

JKP0905A 04/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0446-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0446-2017. Report a data issue: hello@regdatalab.com.